Discover investment opportunities in Top 3 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 3 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 3 Stocks Under $1 using our Smart AI Filter.
8 stocks found for "Top 3 Stocks Under $1"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.18 | ±100.0% | -1.1 | 0.00% | |||
0.76 | ±100.0% | -0.1 | 0.00% | |||
1.01 | ±72.3% | -3.1 | 0.00% | |||
0.15 | ±100.0% | -0.2 | 0.00% | |||
0.65 | ±93.4% | -1.0 | 0.00% | |||
0.64 | ±100.0% | -0.4 | 0.00% | |||
1.11 | ±100.0% | — | 0.00% | |||
0.86 | ±55.0% | 41.8 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Oncolytics Biotech (ONCY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read moreDiscover why Zacks rates Healthcare Triangle as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore HCTI's heavy reliance on top clients amid liquidity issues and ongoing losses.
Read moreQ: What sectors do the top three stocks under $1, like KXIN, operate in?
A: KXIN operates in the automotive sector, specifically focusing on electric vehicles in China. It provides opportunities due to the rising demand for sustainable transportation. Investors should consider sector-specific risks such as regulatory changes and competition.
Q: Is VTAK a good choice for growth-focused investors?
A: VTAK operates in the biotech sector with a focus on innovative healthcare solutions. Some investors find biotech stocks appealing for growth due to potential breakthroughs, but they are typically high-risk and influenced by research outcomes and regulatory approvals.
Q: How does NUWE's market position affect its investment appeal?
A: NUWE, in the biomedical field, offers investment appeal through potential advancements in personalized medicine. Its position could be attractive to investors interested in innovative healthcare solutions, though it carries high research and regulatory risks.
Q: How volatile is VXRT and what factors contribute to it?
A: VXRT, a biotechnology firm, is often subject to high volatility due to its focus on vaccines. Factors like clinical trial outcomes, FDA approvals, and competitive pressures in the biotech sector contribute to its stock price fluctuations.
Q: What income potential does ONCY offer to investors?
A: ONCY, a biotech firm, typically attracts investors looking for growth rather than income. It may not offer dividends, focusing instead on developmental drugs, which entail high-risk but potentially high-reward scenarios.
Q: In what way does HCTI's industry impact its risk profile?
A: HCTI, involved in tech and innovations, can present high risk due to fast-paced changes and competitive pressures in technology. The industry's evolving nature requires firms to innovate rapidly, contributing to potential volatility and investment risk.